Keyphrases
Advisory Group
100%
Booster Dose
33%
Clinical Trial Data
33%
CYD-TDV
100%
Dengue
66%
Dengue Vaccine
100%
Excess Risk
33%
Global Policy
33%
Highly Sensitive
33%
Immunization
100%
Immunization Schedule
33%
Immunization Status
33%
Population Benefit
33%
Rapid Diagnostic Test
33%
Retrospective Analysis
33%
Screening Strategy
33%
Seroprevalence
33%
Seroprevalence Rate
33%
Serostatus
66%
Severe Dengue
33%
Vaccination
66%
Vaccination Strategy
33%
Vaccine Dose
33%
Vaccine Evaluation
33%
Vaccinees
33%
Medicine and Dentistry
Booster Dose
33%
Clinical Trial
33%
Dengue Fever
66%
Dengue Vaccine
100%
Rapid Diagnostic Test
33%
Seroprevalence
66%
Severe Dengue
33%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
33%
Dengue
66%
Dengue Vaccine
100%
Seroprevalence
66%
Severe Dengue
33%
Immunology and Microbiology
Booster Dose
33%
Dengue Fever
100%
Dengue Vaccine
100%
Seroprevalence
66%
Mathematics
Excess Risk
100%
Retrospective Analysis
100%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
50%
Serial Analysis of Gene Expression
50%
Seroprevalence
100%